Insulin-like growth factor I (IGF-I) genotypes study in Chinese idiopathic short stature children

2006 ◽  
Author(s):  
Elim Man
1988 ◽  
Vol 119 (3) ◽  
pp. 333-338 ◽  
Author(s):  
A. Silbergeld ◽  
L. Jaber ◽  
P. Lilos ◽  
Z. Laron

Abstract. Insulin-like growth factor I levels were measured in a parallel fashion in 77 extracted sera using the INCSTAR RIA (radioimmunoassay) and in the EDTA plasma of the same subjects by the NICHOLS RIA. The subjects suffered from untreated hGH deficiency, short stature, delayed and precocious puberty and acromegaly. Significant differences (P < 0.05) were found between the mean IGF-I levels of all groups using both RIA systems. However, using the INCSTAR RIA, 85% of IGF-I values in untreated hGH deficiency were below normal, and a rise in IGF-I detected in the sera of all 5 patients who were treated with hGH. Using NICHOLS RIA, 55% of basal IGF-I values were below normal and a hGH-stimulated rise in IGF-I was found in only two of the treated patients. The INCSTAR RIA seems more precise and reproducible than the NICHOLS RIA and enables better discrimination of hGH-deficient patients from age-matched controls.


Author(s):  
U N Wijayanti

Background : Insulin-like growth factor I (IGF-I) is a polypeptide hormone produced mainly by the liver in response to the endocrine GH stimulus, but it is also secreted by multiple tissues for autocrine/paracrine purposes. IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions). IGF-I is a closely regulated hormone. Low IGF-1 level are observed in GH deficiency or GH resistence. If acquired in childhood, these condition result short stature. Currently the best characterized conditions of IGF-I deficiency are Laron Syndrome, in children; liver cirrhosis, in adults; aging including age-related-cardiovascular and neurological diseases; and more recently, intrauterine growth restriction. Most GH resistence in childhood is mild to moderate, with causes ranging from poor nutrition to severe systemic illness. The purpose of this case report  is to summarize the decreasing list of roles of IGF-I underlying pathological desease. Case : The patients were hospitalized with short stature weight 18  kg, height 118 cm (under 3SD), The patient suffering chronic infection sience 2 years old with repeatly bronchiectasis infection. She has n't had menarche and episode Of hypoglycemia until nowand result examination Trigliseride : 95 mg/dl (normal : 30-150 ),Hemoglobin 8,1 g/dl, WBC 5,3 thousand/µl, Platelet 109 thousand/µl, Glucose 80 mg/dl, HDL: 21 mg/dl, LDL : 45 mg/dl, TSHs : 2,0 µIUmol/l, FT4: 12.16 ¾mol/l, Estradiol : < 11.80 pg/ml ,  FSH : 0.54 mlU/ml, LH : < 0.07 mlU/ml GH : 4.63 ng/ml, IGF-1 : < 25 ng/ml, Cranium scan no found tumor hypothalamic and pituitary, Bone marrow examination  supports the diagnosis of MDS with multilineage dysplasia , MSCT of the thorax showed suspect cystic bronchiectasis, would be a Congenital Cystic AdenomatoidMalformation.and cytogenetic analized showed Chromosome number of  single cell : 46, There were 20 cell been analized and 8  of cell were been counted Kariotipe : 46,XX,del 5q31. Conclusion : Low IGF-1 level in this patient due to severe systemic illness (recurrent infection of congenital cysticadenomatoid malformation (CCAM) and deletion 5qMyelodisplatia syndrome (MDS)and poor nutrition.


Sign in / Sign up

Export Citation Format

Share Document